PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Genetics, Department of Pediatrics, Center for Drug Discovery Innovation, Program in Immunology, Institute for Genomic Medicine, 9500 Gilman Drive MC 0762, La Jolla, California 92093, United States.\', \'Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555, United States.\', \'Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive MC 0762, La Jolla, California 92093, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acs.jmedchem.1c00566
?:doi
?:hasPublicationType
?:journal
  • Journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 34570513
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.567
?:rankingScore_hIndex
  • 231
is ?:relation_isRelatedTo_publication of
?:title
  • Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all